RA Capital Management - ELIEM THERAPEUTICS INC ownership

ELIEM THERAPEUTICS INC's ticker is and the CUSIP is 28658R106. A total of 44 filers reported holding ELIEM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RA Capital Management ownership history of ELIEM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$34,586,733
-6.1%
13,150,8490.0%0.68%
-2.0%
Q2 2023$36,822,377
-3.4%
13,150,8490.0%0.70%
-19.5%
Q1 2023$38,137,462
-21.0%
13,150,8490.0%0.86%
-11.8%
Q4 2022$48,263,616
+13.6%
13,150,8490.0%0.98%
+8.1%
Q3 2022$42,477,000
+7.0%
13,150,8490.0%0.91%
-14.4%
Q2 2022$39,716,000
-64.0%
13,150,8490.0%1.06%
-56.0%
Q1 2022$110,336,000
-19.8%
13,150,8490.0%2.41%
-0.7%
Q4 2021$137,558,000
-41.8%
13,150,8490.0%2.42%
-26.0%
Q3 2021$236,452,00013,150,8493.28%
Other shareholders
ELIEM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
RA Capital Management 13,150,849$110,336,0002.41%
Monashee Investment Management LLC 227,201$1,906,0000.55%
SILVERARC CAPITAL MANAGEMENT, LLC 88,279$741,0000.31%
SAMLYN CAPITAL, LLC 2,130,237$17,873,0000.26%
Parkwood LLC 41,133$345,0000.06%
Woodline Partners LP 373,368$3,133,0000.05%
Hudson Bay Capital Management LP 100,000$839,0000.01%
TUDOR INVESTMENT CORP ET AL 46,092$387,0000.01%
Chicago Partners Investment Group LLC 22,209$81,0000.01%
Point72 Asset Management, L.P. 142,333$1,194,0000.01%
View complete list of ELIEM THERAPEUTICS INC shareholders